Update: Market Chatter: Lilly Close to Acquire Cancer Biotech Scorpion Therapeutics for $2.5 Billion-March 2024-www.financetom.com

Update: Market Chatter: Lilly Close to Acquire Cancer Biotech Scorpion Therapeutics for $2.5 Billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Update: Market Chatter: Lilly Close to Acquire Cancer Biotech Scorpion Therapeutics for $2.5 Billion

Jan 10, 2025 1:28 PM

04:02 PM EST, 01/10/2025 (MT Newswires) -- (Updates with response from Eli Lilly ( LLY ) in the last paragraph.)

Eli Lilly ( LLY ) is nearing a deal to acquire privately held Scorpion Therapeutics, valuing the Boston-based company working on potential cancer treatments at around $2.5 billion, according to the Financial Times, citing sources.

A deal could be announced in coming days, the sources told the newspaper.

Lilly declined to comment to MT Newswires, while Scorpion Therapeutics did not immediately respond.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 799.46, Change: +12.24, Percent Change: +1.55

Previous page： Mgic Investment Insider Sold Shares Worth $781,110, According to a Recent SEC Filing Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Mgic Investment Insider Sold Shares Worth $781,110, According to a Recent SEC Filing

Jun 6, 2025

12:45 PM EDT, 06/06/2025 (MT Newswires) -- Salvatore A Miosi, President & COO, on June 05, 2025, sold 30,000 shares in Mgic Investment ( MTG ) for $781,110. Following the Form 4 filing with the SEC, Miosi has control over a total of 694,245 common shares of the company, with 309,401 shares held directly and 384,844 controlled indirectly. SEC Filing:...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Viavi Solutions Insider Sold Shares Worth $761,842, According to a Recent SEC Filing

Jun 6, 2025

12:44 PM EDT, 06/06/2025 (MT Newswires) -- Ilan Daskal, Executive Vice President, CFO, on June 04, 2025, sold 82,095 shares in Viavi Solutions ( VIAV ) for $761,842. SEC Filing: https://www.sec.gov/Archives/edgar/data/912093/000091209325000075/xslF345X05/form4.xml Price: 9.46, Change: +0.15, Percent Change: +1.61 ...

Phathom Pharmaceuticals Shares Surge After FDA Grants 10-Year Exclusivity for Acid-Reducing Drug

Jun 6, 2025

12:54 PM EDT, 06/06/2025 (MT Newswires) -- Phathom Pharmaceuticals ( PHAT ) shares jumped nearly 104% in recent Friday trading after the company said the US Food and Drug Administration approved its citizen petition to grant full New Chemical Entity exclusivity for its acid-reducing drug, Voquezna, or vonoprazan. The FDA confirmed it will update the Orange Book to reflect a...